UNSPSC 51143402: Acetaminophen/dichloralphenazone/isometheptene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN105. This VA Drug Class (CN105) classifies this compound as belonging to the group ANTIMIGRAINE AGENTS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51143402 Acetaminophen/dichloralphenazone/isometheptene is a Commodity code that in recent state and local procurement activity primarily designates pharmaceutical products and drug-related supplies purchased by county health departments and state health agencies. The recent opportunities tagged under this code show little alignment with the specific acetaminophen-based formulation the code nominally describes; instead, solicitations reflect procurement of naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through cooperative purchasing mechanisms and direct state contracts. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local facilities including Oregon). The mix reflects health-focused public entities with recurring procurement demand rather than concentrated repeat buyers in any single jurisdiction.

Recent activity centers in Florida and Minnesota, with additional procurement interest from Texas and Oregon through cooperative mechanisms. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, due March 26, 2026), which established multiple contracts effective July 1, 2026, through authorized wholesalers with a two-year term; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring vendor capabilities for a Direct-to-Manufacturer Prescriptions program. The code's mismatch with recent solicitations suggests procurement offices use it as a catch-all pharmaceutical tag rather than as a precise commodity classifier, limiting its utility for targeting acetaminophen-based product sales specifically.